Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by Str8Shuteron Jun 22, 2023 7:13pm
97 Views
Post# 35510307

RE:RE:RE:Correction

RE:RE:RE:Correction First of all, let's be clear that there are actually 896 lots on the Ask side at this moment, NOT on the Bid side.  On the Bid, there are currently zero lots.  In other words, as of the close of today's market there were sellers but no buyers.

Suggest referring to published info on the TSX website.  You can bookmark this site in your web browser for future reference.  Just click on the Standard Trading Units heading:
[url=https://www.tsx.com/trading/toronto-stock-exchange/order-types-and-features/order-types#]TMX TSX | TSXV - Order Types[/url]

You will see that each board lot is 1,000 units (warrants in this case), since they are priced at under $0.10.  So, 896 lots on the Ask represent 896,000 warrants that folks are lined up to sell for $4,480 in aggregate.  With 8 .WT warrant redemptions required to purchase a single SZLS share at $0.065, the 896,000 warrants on the Ask represent the rights to purchase a total of 112,000 shares of SZLS for $7,280.

I think I got those details straight, but I will stand to be corrected.  GLTA
<< Previous
Bullboard Posts
Next >>